Focus topics

Implementation of the adjustments from the EU ADRA project

Launched in the EU, the ADRA project aims to adjust the dosage regimens and withdrawal periods of antibiotics with older authorisations without clinical studies. Swissmedic intends to adopt the results of the project for the relevant veterinary medicinal products authorised in Switzerland as soon as specific recommendations are communicated by the EMA. These adjustments are part of a coordinated signal procedure in which all veterinary medicinal products from a group (active substance-target animal species-route of administration) will be updated at the same time.